Neonatal innate immunity in allergy development

Current Opinion in Pediatrics

Volumn 21, Issue 6, 2009, Pages 762-769

  Belderbos, Mirjam ^a,b   Levy, Ofer ^b   Bont, Louis ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Allergy; Asthma; Neonate; Review; Toll like receptor

Indexed keywords

ALLERGEN; ALPHA GALACTOSYLCERAMIDE; ANTIALLERGIC AGENT; ANTIGEN; CRX 675; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; INTERLEUKIN 8; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ALLERGY; ASTHMA; BIFIDOBACTERIUM; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; INNATE IMMUNITY; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL;

ALLERGENS; ANIMALS; ANTIGENS; CYTOKINES; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNITY, INNATE; INFANT, NEWBORN; MICE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 74549152609     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3283325e3a     Document Type: Review

References (80)

1. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4:553-564.
2. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7:379-390.
3. Drohan L, Harding JJ, Holm B, et al. Selective developmental defects of cord blood antigen-presenting cell subsets. Hum Immunol 2004; 65:1356-1369.
4. Belderbos ME, Bleek G, Levy O. Skewed pattern of toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol 2009 [Epub ahead of print]
5. Novak N, Bieber T. 2. Dendritic cells as regulators of immunity and tolerance. J Allergy Clin Immunol 2008; 121:S370-S374.
6. Eger KA, Sundrud MS, Motsinger AA, et al. Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions. PLoS One 2006; 1:e50.
7. Levy O, Zarember KA, Roy RM, et al. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004; 173:4627-4634.
8. Levy O, Coughlin M, Cronstein BN, et al. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol 2006; 177:1956-1966.
9. Vanden ES, Goriely S, De WD, et al. Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. Eur J Immunol 2006; 36:21-26.
10. Krumbiegel D, Zepp F, Meyer CU. Combined toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Hum Immunol 2007; 68:813-822.
11. Goriely S, Van LC, Dadkhah R, et al. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J Exp Med 2004; 199:1011-1016.
12. Yan SR, Qing G, Byers DM, et al. Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 2004; 72:1223-1229.
13. Lappalainen M, Roponen M, Pekkanen J, et al. Maturation of cytokine-producing capacity from birth to 1 yr of age. Pediatr Allergy Immunol 2009 [Epub ahead of print]
14. De WD, Tonon S, Olislagers V, et al. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 2003; 21:277-281.
15. Aksoy E, Albarani V, Nguyen M, et al. Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 2007; 109:2887-2893.
16. Levy O, Suter EE, Miller RL, Wessels MR. Unique efficacy of toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 2006; 108:1284-1290.
17. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006; 117:979-987.
18. Kaiko GE, Horvat JC, Beagley KW, Hansbro PM. Immunological decisionmaking: how does the immune system decide to mount a helper T-cell response? Immunology 2008; 123:326-338.
19. De WD, Olislagers V, Goriely S, et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004; 103:1030-1032.
20. Forster-Waldl E, Sadeghi K, Tamandl D, et al. Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res 2005; 58:121-124.
21. Yerkovich ST, Wikstrom ME, Suriyaarachchi D, et al. Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr Res 2007; 62:547-552.
22. Sadeghi K, Berger A, Langgartner M, et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007; 195:296-302.
23. Goriely S,Molle C, Nguyen M, et al. Interferon regulatory factor 3 is involved in toll-like receptor 4 (TLR4)-and TLR3-induced IL-12p35 gene activation. Blood 2006; 107:1078-1084.
24. LeBouder E, Rey-Nores JE, Raby AC, et al. Modulation of neonatal microbial recognition: TLR-mediated innate immune responses are specifically and differentially modulated by human milk. J Immunol 2006; 176:3742-3752.
25. Wills-Karp M. Complement activation pathways: a bridge between innate and adaptive immune responses in asthma. Proc Am Thorac Soc 2007; 4:247-251.
26. Drew JH, Arroyave CM. The complement system of the newborn infant. Biol Neonate 1980; 37:209-217.
27. Schnurr M, Toy T, Shin A, et al. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 2005; 105:1582-1589.
28. Levy O, Jean-Jacques RM, Cywes C, et al. Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release. Infect Immun 2003; 71:6344-6353.
29. Vekemans J, Amedei A, Ota MO, et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 2001; 31:1531-1535.
30. Tse K, Horner AA. Allergen tolerance versus the allergic march: the hygiene hypothesis revisited. Curr Allergy Asthma Rep 2008; 8:475-483.
31. Ege MJ, Bieli C, Frei R, et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol 2006; 117:817-823.
32. Miller RL, Chew GL, Bell CA, et al. Prenatal exposure, maternal sensitization, and sensitization in utero to indoor allergens in an inner-city cohort. Am J Respir Crit Care Med 2001; 164:995-1001.
33. Jones CA, Holloway JA, Popplewell EJ, et al. Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. J Allergy Clin Immunol 2002; 109:858-866.
34. Schaub B, Liu J, Hoppler S, et al. Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J Allergy Clin Immunol 2009; 123:774-782.
35. Gereda JE, Leung DY, Thatayatikom A, et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000; 355:1680-1683.
36. Schram-Bijkerk D, Doekes G, Douwes J, et al. Bacterial and fungal agents in house dust and wheeze in children: the PARSIFAL study. Clin Exp Allergy 2005; 35:1272-1278.
37. Oddy WH, Peat JK. Breastfeeding, asthma, and atopic disease: an epidemiological review of the literature. J Hum Lact 2003; 19:250-261.
38. Ball TM, Castro-Rodriguez JA, Griffith KA, et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000; 343:538-543.
39. Rothers J, Stern DA, Spangenberg A, et al. Influence of early day-care exposure on total IgE levels through age 3 years. J Allergy Clin Immunol 2007; 120:1201-1207.
40. Smit LA, Siroux V, Bouzigon E, et al. CD14 and toll-like receptor gene polymorphisms, country living, and asthma in adults. Am J Respir Crit Care Med 2009; 179:363-368.
41. Prescott SL, Noakes P, Chow BW, et al. Presymptomatic differences in tolllike receptor function in infants who have allergy. J Allergy Clin Immunol 2008; 122:391-399; 399.e1-5
42. Trompette A, Divanovic S, Visintin A, et al. Allergenicity resulting from functional mimicry of a toll-like receptor complex protein. Nature 2009; 457:585-588.
43. Lam D, Ng N, Lee S, et al. Airway house dust extract exposures modify allergen-induced airway hypersensitivity responses by TLR4-dependent and independent pathways. J Immunol 2008; 181:2925-2932.
44. Jeon SG, Oh SY, Park HK, et al. TH2 and TH1 lung inflammation induced by airway allergen sensitization with low and high doses of double-stranded RNA. J Allergy Clin Immunol 2007; 120:803-812.
45. Piggott DA, Eisenbarth SC, Xu L, et al. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J Clin Invest 2005; 115: 459-467.
46. Creticos PS, Schroeder JT, Hamilton RG, et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006; 355:1445-1455.
47. Hammad H, Chieppa M, Perros F, et al. House dust mite allergen induces asthma via toll-like receptor 4 triggering of airway structural cells. Nat Med 2009; 15:410-416.
48. Ashino S, Wakita D, Zhang Y, et al. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung. Int Immunol 2008; 20:259-266.
49. Delgado MF, Coviello S, Monsalvo AC, et al. Lack of antibody affinity maturation due to poor toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 2009; 15:34-41.
50. Kneyber MC, van Woensel JB, Uijtendaal E, et al. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial. Pediatr Pulmonol 2008; 43:142-149.
51. Moisan J, Camateros P, Thuraisingam T, et al. TLR7 ligand prevents allergeninduced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am J Physiol Lung Cell Mol Physiol 2006; 290:L987-L995.
52. Akbari O, Faul JL, Hoyte EG, et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 2006; 354:1117-1129.
53. Balaci L, Spada MC, Olla N, et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am J Hum Genet 2007; 80:1103-1114.
54. Senthilselvan A, Rennie D, Chenard L, et al. Association of polymorphisms of toll-like receptor 4 with a reduced prevalence of hay fever and atopy. Ann Allergy Asthma Immunol 2008; 100:463-468.
55. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: a randomized, doubleblind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:192-198.
56. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121:116-121.
57. Sel S, Wegmann M, Sel S, et al. Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J Immunol 2007; 178:7805-7813.
58. Taylor RC, Richmond P, Upham JW. Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol 2006; 117:1148-1154.
59. Newcomb DC, Peebles RS Jr. Bugs and asthma: a different disease? Proc Am Thorac Soc 2009; 6:266-271.
60. Schroder NW, Arditi M. The role of innate immunity in the pathogenesis of asthma: evidence for the involvement of toll-like receptor signaling. J Endotoxin Res 2007; 13:305-312.
61. Redecke V, Hacker H, Datta SK, et al. Cutting edge: activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172:2739-2743.
62. Phipps S, Lam CE, Kaiko GE, et al. Toll/IL-1 signaling is critical for house dust mite-specific Th1 and Th2 responses. Am J Respir Crit Care Med 2009; 179:883-893.
63. Dabbagh K, Dahl ME, Stepick-Biek P, Lewis DB. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J Immunol 2002; 168:4524-4530.
64. Eisenbarth SC, Piggott DA, Huleatt JW, et al. Lipopolysaccharide- enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196:1645-1651.
65. Luhrmann A, Grote K, Stephan M, et al. Local pulmonary immune stimulation by the toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent. Immunol Lett 2007; 108:167-173.
66. Chiou YL, Lin CY. Der p2 activates airway smooth muscle cells in a TLR2/ MyD88-dependent manner to induce an inflammatory response. J Cell Physiol 2009; 220:311-318.
67. Kim YK, Oh SY, Jeon SG, et al. Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol 2007; 178:5375-5382.
68. Scordamaglia F, Balsamo M, Scordamaglia A, et al. Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol 2008; 121:479-485.
69. Dalle JH, Menezes J, Wagner E, et al. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res 2005; 57:649-655.
70. Kim HY, Pichavant M, Matangkasombut P, et al. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells. J Immunol 2009; 182:3252-3261.
71. Stock P, Lombardi V, Kohlrautz V, Akbari O. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J Immunol 2009; 182:5116-5122.
72. Werling D, Jann OC, Offord V, et al. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol 2009; 30:124-130.
73. Willart MA, Lambrecht BN. The danger within: endogenous danger signals, atopy and asthma. Clin Exp Allergy 2009; 39:12-19.
74. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-1079.
75. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007:CD006475.
76. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with toll-like receptor agonists and antagonists. Nat Med 2007; 13:552-559.
77. Gauvreau GM, Hessel EM, Boulet LP, et al. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am J Respir Crit Care Med 2006; 174:15-20.
78. Casale TB, Kessler J, Romero FA. Safety of the intranasal toll-like receptor 4 agonist CRX-675 in allergic rhinitis. Ann Allergy Asthma Immunol 2006; 97:454-456.
79. Morishima Y, Ishii Y, Kimura T, et al. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur J Immunol 2005; 35:2803-2814.
80. Giaccone G, Punt CJ, Ando Y, et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002; 8:3702-3709.